Merck to acquire Prometheus Biosciences & its lead IBD drug

The latest stories trending on MedCity News.

Editor's Pick

Top Story Merck's $11B Prometheus Acquisition Brings IBD Drug & Precision Medicine Platform Merck is acquiring Prometheus Biosciences and a lead drug candidate in development for inflammatory bowel disorders. The deal comes as Merck looks for drug prospects that could make up for revenue declines facing blockbuster seller Keytruda, which faces patent expirations in coming years. Sponsored Content The Vibe at Vive: A Progress Report on Healthcare Transformation Presented by Season Health and MedCity News Josh Hix, Season Health CEO, discussed how his food-as-medicine company helps people with chronic conditions. He also talked about how Season Health secured funding from venture capital investors such as Andreessen Horowitz and 8VC. Watch it here!

Featured News

Why Effective and Efficient Clinical Trial Operations Are More Complex and More Important than Ever in a Post-Pandemic World Anita Nelsen, Senior Vice President of Clinical Trial Operations at Allucent, shares her insights on how to navigate the drug development landscape. How Gamida Cell's FDA Approval Could Reduce Racial Disparities in Stem Cell Transplants The FDA approved Omisirge, an allogeneic cell therapy from Gamida Cell that could improve access to stem cell transplants as treatments for blood cancers. The biotech makes its therapy from umbilical cord blood. Wellstar Health System Partners with Clear for Identity Verification Initiative Clear, a company founded to help travelers breeze through airport security lines, is now pursuing partnerships with health systems. Georgia-based Wellstar Health System recently announced it will use the company's identity verification technology to give patients secure and seamless access to their personal health information. Horizon Healthcare Services Taps Talkiatry for Virtual Psychiatric Care Talkiatry is now available to Horizon Healthcare Services' commercial members at no additional cost, giving 3.6 million people access to the virtual mental health services. The company treats patients ages 5 years and older for conditions including anxiety, depression and bipolar disorder.  Express Scripts Launches New Solutions To Advance Drug Price Transparency Express Scripts released several new solutions last week that aim to improve drug price transparency, including a cap on out-of-pocket costs for prescription drugs for consumers. The news comes amid increasing scrutiny against pharmacy benefit managers. Innovaccer Launches Conversational AI Assistant to Help Health System, Payer Execs Innovaccer launched a new product called Sara, a conversational AI assistant designed to help executives at health systems and payers make better use of their data. It allows executives can ask complex questions about their organization's patients or members and get immediate answers on clinical, financial or operational metrics.

Resources

Startup 101: Providing Best Practices for Healthcare Entrepreneurs Get the tools necessary to make the right decisions, know what strategies to avoid, and learn how to approach potential healthcare customers. Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe